Former Cytyc execs Sullivan, Levangie to lead Warburg-backed firm

By Mass High Tech Staff

Hologic wins FDA OK for two new HPV tests [March 13, 2009]

Inside Fast Growth Technology Companies: Fast-growth firms see stock plummet by end of 2008 [January 16, 2009]

Bowen takes CFO helm at Abiomed [December 22, 2008]

Report: Tech tops list of insider stock sales [October 17, 2008]

Private equity investor Warburg Pincus and two former Cytyc Corp. executives have formed a Boston-based firm, Constitution Medical Investors Inc., to serve as a vehicle to make acquisitions in the health-care sector, the partners announced.

The former Cytyc executives in charge of the new investment fund are Patrick Sullivan, a former chief executive of Marlborough-based Cytyc, and Daniel Levangie, who was the medical technology company’s executive vice president and head of its surgical products division. Sullivan was most recently chairman of Hologic Inc. (Nasdaq: HOLX), the Bedford medical devices firm which acquired Cytyc in October 2007. Levangie is currently a director of Hologic.

Constitution Medical says it plans to acquire health care-related technologies and companies. It was not disclosed how much capital Warburg Pincus has committed to the fund.

Warburg Pincus is a global private equity investor with offices in the United States, Europe and Asia. The firm says it has invested more than $29 billion in more than 600 companies around the world, including $6.6 billion invested in health care-related concerns.

Sullivan announced in May he would resign from his post as chairman of Hologic. Hologic CEO Jack Cumming has taken on the added role of company chairman.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.